INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $757,774 | -9.5% | 23,965 | +16.8% | 0.00% | 0.0% |
| Q2 2023 | $837,009 | +13.4% | 20,525 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $738,096 | +6.7% | 19,804 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $692,043 | -33.4% | 19,835 | +6.7% | 0.00% | 0.0% |
| Q3 2022 | $1,039,000 | +14.4% | 18,582 | +5.9% | 0.00% | 0.0% |
| Q2 2022 | $908,000 | -51.3% | 17,547 | -31.6% | 0.00% | 0.0% |
| Q1 2022 | $1,865,000 | -44.4% | 25,670 | -9.5% | 0.00% | -50.0% |
| Q4 2021 | $3,355,000 | -79.4% | 28,375 | -76.6% | 0.00% | -81.8% |
| Q3 2021 | $16,289,000 | -12.2% | 121,428 | +6.0% | 0.01% | -8.3% |
| Q2 2021 | $18,556,000 | +825.5% | 114,605 | +358.8% | 0.01% | +1100.0% |
| Q1 2021 | $2,005,000 | +48.5% | 24,981 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $1,350,000 | +516.4% | 24,824 | +137.8% | 0.00% | – |
| Q2 2020 | $219,000 | – | 10,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |